Home › Funds › Hartford Funds Management Co LLC › VRTX

Hartford Funds Management Co LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Hartford Funds Management Co LLC reported holding 3,382 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 0.13% of its reported portfolio and ranking #33 among its reported holdings. Hartford Funds Management Co LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.38K sh
Reported value held$1.77M
Portfolio Weight0.13%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hartford Funds Management Co LLC's VRTX position evolved

Hartford Funds Management Co LLC first disclosed a stake in VRTX in Q3 2023 at 826 shares (US$287K). The position peaked in Q3 2026 at 3,382 shares, worth US$1.8M. Across 13 filings, Hartford Funds Management Co LLC increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,382 shares valued at US$1.8M — an increase of 96 shares quarter over quarter.. Notable position changes include a 73% trim in Q2 2025 (shares fell 12% over the following quarter), a 332% increase in Q3 2025 (shares rose 16% over the following quarter), a 97% increase in Q4 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 826 $287.38K New
Q4 2023 890 $361.97K Add
Q1 2024 975 $407.36K Add
Q2 2024 1.03K $483.98K Add
Q3 2024 1.07K $499.79K Add
Q4 2024 1.12K $451.43K Add
Q1 2025 1.36K $659.38K Add
Q2 2025 361 $781.88K Reduce
Q3 2025 1.56K $611.99K Add
Q4 2025 3.07K $1.39M Add
Q1 2026 3.10K $1.39M Add
Q2 2026 3.29K $1.63M Add
Q3 2026 3.38K $1.77M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Hartford Funds Management Co LLC held VRTX?

Hartford Funds Management Co LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Hartford Funds Management Co LLC's current position in VRTX?

As of Q3 2026, Hartford Funds Management Co LLC holds 3.38K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $1.77M, representing 0.13% of its reported portfolio and ranking #33.

Has Hartford Funds Management Co LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Hartford Funds Management Co LLC increased its position in VRTX. The position peaked in Q3 2026 at 3.38K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.